Echinocandin-induced eosinophilia: a case report.

Area of Science:

• Pharmacology
• Clinical Medicine
• Immunology

Background:

• Drug-induced eosinophilia is a rare but serious adverse drug reaction.
• Echinocandin antifungals, particularly caspofungin, have been implicated in causing eosinophilia.
• Early diagnosis and management are crucial to prevent severe organ damage.

Observation:

• A patient developed eosinophilia following caspofungin administration.
• The patient subsequently experienced eosinophilia upon re-challenge with anidulafungin, another echinocandin.
• This suggests a potential cross-reactivity or shared mechanism among echinocandins.

Findings:

• The presented case is the first to report eosinophilia associated with both caspofungin and anidulafungin.
• Discontinuation of both caspofungin and anidulafungin led to the resolution of eosinophilia.
• This supports a causal relationship between these echinocandins and the observed eosinophilic reaction.

Implications:

• This case expands the understanding of drug-induced eosinophilia within the echinocandin class.
• It underscores the importance of considering echinocandins in patients presenting with unexplained eosinophilia.
• Further investigation into the immunologic mechanisms underlying echinocandin-induced eosinophilia is warranted.